echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Active Ingredient Products News > The Safety of Selegiline

    The Safety of Selegiline

    • Last Update: 2023-05-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Selegiline, also known as l-deprenyl, is a medication that is used to treat Parkinson's disease.
    It is a selective monoamine oxidase-B (MAO-B) inhibitor, which means that it blocks the action of an enzyme that breaks down certain chemicals in the brain.
    This can help to increase the levels of certain chemicals, such as dopamine, which are depleted in Parkinson's disease.


    Selegiline is generally considered to be a safe medication when used as directed.
    However, it is important to note that it can have serious side effects, particularly at higher doses.
    It is also important to use selegiline carefully and under the guidance of a healthcare professional, as it can interact with other medications and may not be suitable for certain people.


    One of the main safety concerns with selegiline is the risk of serotonin syndrome, which is a potentially life-threatening condition that occurs when the levels of serotonin in the body become too high.
    Serotonin is a chemical that is involved in mood regulation and other functions in the body.
    Selegiline can increase the levels of serotonin in the body, which can lead to serotonin syndrome if it is taken in combination with other medications that also increase serotonin levels.


    Symptoms of serotonin syndrome can include confusion, agitation, hallucinations, muscle rigidity, and changes in blood pressure.
    If you experience any of these symptoms while taking selegiline, it is important to seek medical attention immediately.


    Another potential safety concern with selegiline is the risk of a condition called tardive dyskinesia.
    This is a movement disorder that can occur as a result of long-term use of certain medications, including selegiline.
    It is characterized by involuntary movements of the face, tongue, or limbs.
    While the risk of tardive dyskinesia is generally low with selegiline, it can increase with longer-term use.


    It is important to note that selegiline should not be used in certain people, such as those with a history of heart disease, lung disease, or liver disease.
    It should also not be used in pregnant or breastfeeding women, or in people with a history of drug abuse.


    In conclusion, selegiline is a medication that is used to treat Parkinson's disease, and is generally considered to be safe when used as directed.
    However, it can have serious side effects, particularly at higher doses, and should be used carefully and under the guidance of a healthcare professional.
    It is important to be aware of the potential risks of serotonin syndrome and tardive dyskinesia, and to seek medical attention if any symptoms occur.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.